Credit: C. Breuer/Nationwide Children's Hospital
Researchers at Nationwide Children's Hospital are currently leading the only FDA-approved investigational study looking at the efficacy and outcomes of tissue-engineered veins implanted into children with fatal heart defects. This photo shows that within 24 hours, all the cells on the vascular graft are replaced by the patient’s own native cells.